切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2021, Vol. 10 ›› Issue (03) : 138 -143. doi: 10.3877/cma.j.issn.2095-3216.2021.03.004

论著

新冠病毒感染患者并发急性肾损伤与临床预后相关性的Meta分析
罗晴1, 彭婷2, 张伟光3, 程晓巍1, 王滨4,(), 陈意志4,()   
  1. 1. 572013 三亚,解放军总医院海南医院肾脏病科,海南省院士团队创新中心
    2. 572013 海南省三亚市中医院内二科
    3. 100853 北京,解放军总医院第一医学中心肾脏病医学部,解放军肾脏病研究所,肾脏疾病国家重点实验室,国家慢性肾病临床医学研究中心,肾脏疾病研究北京市重点实验室
    4. 572013 三亚,解放军总医院海南医院肾脏病科,海南省院士团队创新中心;100853 北京,解放军总医院第一医学中心肾脏病医学部,解放军肾脏病研究所,肾脏疾病国家重点实验室,国家慢性肾病临床医学研究中心,肾脏疾病研究北京市重点实验室
  • 收稿日期:2020-08-24 出版日期:2021-06-28
  • 通信作者: 王滨, 陈意志
  • 基金资助:
    海南省院士创新平台科研专项(YSPTZX202026)

Meta analysis of the correlation between acute kidney injury and clinical prognosis in patients with SARS-CoV-2 infection

Qing Luo1, Ting Peng2, Weiguang Zhang3, Xiaowei Cheng1, Bin Wang4,(), Yizhi Chen4,()   

  1. 1. Department of Nephrology, Hainan Hospital of Chinese PLA General Hospital, Hainan Academician Team Innovation Center
    2. Department of Internal Medicine II, Sanya Hospital of Traditional Chinese Medicine; Sanya 572013, Hainan Province
    3. Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases, Beijing 100853; China
    4. Department of Nephrology, Hainan Hospital of Chinese PLA General Hospital, Hainan Academician Team Innovation Center; Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases, Beijing 100853; China
  • Received:2020-08-24 Published:2021-06-28
  • Corresponding author: Bin Wang, Yizhi Chen
引用本文:

罗晴, 彭婷, 张伟光, 程晓巍, 王滨, 陈意志. 新冠病毒感染患者并发急性肾损伤与临床预后相关性的Meta分析[J]. 中华肾病研究电子杂志, 2021, 10(03): 138-143.

Qing Luo, Ting Peng, Weiguang Zhang, Xiaowei Cheng, Bin Wang, Yizhi Chen. Meta analysis of the correlation between acute kidney injury and clinical prognosis in patients with SARS-CoV-2 infection[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2021, 10(03): 138-143.

目的

系统评价并且定量分析感染新冠病毒患者病程中急性肾损伤(AKI)的发生率及其同临床预后的关系。

方法

通过检索中国知网、维普、万方、中国生物医学文献数据库(CBM)、PubMed和Embase的文献,依据NOS质量评价表进行质量评价,由2研究者独立提取数据,采用Review Manager 5.3软件对所得的数据进行Meta分析。

结果

共纳入17篇文献,Meta分析结果表明,感染新冠病毒患者出现AKI后进展为重症病例的风险显著增加(OR=10.25,95%CI:7.79~13.49,P<0.01),死亡风险亦显著增加(OR=24.38,95%CI:4.87~22.04,P<0.01)。

结论

新冠病毒感染患者的AKI总体发生率并不高,但AKI会增加新冠肺炎患者进展为重症及死亡的概率,因此一旦出现AKI应立即重视并给予相应的处置。

Objective

To systematically evaluate and quantitatively analyze the incidence of AKI in patients with SARS-CoV-2 infection and the relationship between the AKI and clinical prognosis.

Methods

After retrieving databases of CNKI, Weipu, Wanfang, China Biomedical Literature Database (CBM), PubMed, and Embase, the literature quality evaluation was carried out according to the the Newcastle-Ottawa scale (NOS) quality evaluation table. The data was extracted by 2 researchers independently, and the Review Manager 5.3 software was used for the meta-analysis of the obtained data.

Results

A total of 17 studies were included. The meta-analysis results showed that if the patients with SARS-CoV-2 infection had new-onset AKI, they had significantly increased risks of progression to severe cases (OR=10.25, 95%CI: 7.79-13.49, P<0.01) or death (OR=24.38, 95%CI: 4.87-122.04, P<0.01).

Conclusion

The overall incidence of AKI in patients with SARS-CoV-2 infection was not high, but the AKI increased their probability of progressing to severe cases or death. Therefore, once AKI appeared, attention should be paid immediately and corresponding treatment should be given to the patients.

图1 纳入文献筛选流程图
表1 纳入荟萃分析文献的基本情况
表2 文献质量评价表(NOS)
图2 感染新冠病毒患者疾病严重程度同AKI发生之间关系(Meta分析)
图3 13篇新冠肺炎患者发生AKI Meta分析文献发表偏倚分析
图4 感染新冠病毒患者死亡与AKI发生率的关系(Meta分析)
图5 感染新冠病毒患者死亡及AKI发生率关系的亚组分析(Meta分析)
[1]
国家卫生健康委员会,国家中医药管理局. 新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL]. 2020:

URL    
[2]
赵天明,玄坤,刘海霞,等. 新型冠状病毒肺炎概述[J]. 安徽预防医学杂志,2020, 26(1): 38-41.
[3]
Ng JJ, Luo Y, Phua K, et al. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): a meta-analysis [J]. J Infect, 2020, 81(4): 647-679.
[4]
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19 [J]. Kidney Int, 2020, 97(5): 829-838.
[5]
Argenziano MG, Slater CL, Tiao JR, et al. Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series [J]. BMJ, 2020, 369: m1996.
[6]
张维,候维,李侗曾,等. 74例新型冠状病毒肺炎临床特征分析[J]. 首都医科大学学报,2020, 41(2): 161-167.
[7]
Cai Q, Ou P, Yu H, et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China [J]. Allergy, 2020, 75(7): 1742-1752.
[8]
林柳,胡凯元,邵欣宁,等. 新型冠状病毒肺炎患者并发急性肾损伤的临床分析[J]. 实用医学杂志,2020, 36(7): 835-838.
[9]
Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [J]. BMJ, 2020, 368: m1091.
[10]
Colaneri M, Sacchi P, Zuccaro V, et al. Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 [J]. Euro Surveill, 2020, 25(16): 2000460.
[11]
Feng X, Ma L, Liang H, et al. Clinical characteristics and short-term outcomes of severe patients with COVID-19 in Wuhan, China [J]. Front Med (Lausanne), 2020, 7: 491.
[12]
Hu L, Fu Y, Gao Z, et al. Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan, China[J]. Clin Infect Dis, 2020, 71(16): 2089-2098.
[13]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
[14]
Ali H, Daoud A, Mohamed MM, et al. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis [J]. Ren Fail, 2020, 42(1): 393-397.
[15]
Liu YF, Zhang Z, Pan XL, et al. The chronic kidney disease and acute kidney injury involvement in COVID-19 pandemic: a systematic review and meta-analysis [J]. PLoS One, 2021, 16(1): e0244779.
[16]
Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation [J]. Science, 2020, 367(6483): 1260-1263.
[17]
Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing [J]. J Med Virol, 2020, 92(7): 797-806.
[18]
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [J]. Lancet Respir Med, 2020, 8(5): 475-481.
[19]
Zhang G, Hu C, Luo L, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China [J]. J Clin Virol, 2020, 127: 104364.
[20]
Zhao XY, Xu XX, Yin HS, et al. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study [J]. BMC Infect Dis, 2020, 20(1): 311.
[21]
Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China [J]. Kidney Int, 2020, 98(1): 219-227.
[22]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J]. Lancet, 2020, 395(10229): 1054-1062.
[23]
Cao J, Tu WJ, Cheng W, et al. Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China [J]. Clin Infect Dis, 2020, 71(15): 748-755.
[24]
徐申,胡洪涛,胡玉刚,等. 62例危重型新型冠状病毒肺炎并发急性肾损伤的临床特征[J]. 武汉大学学报(医学版), 2020, 41(4): 539-541.
[25]
Wan D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
[1] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[2] 罗旺林, 杨传军, 许国星, 俞建国, 孙伟东, 颜文娟, 冯志. 开放性楔形胫骨高位截骨术不同植入材料的Meta分析[J]. 中华关节外科杂志(电子版), 2023, 17(06): 818-826.
[3] 杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[6] 张再博, 王冰雨, 焦志凯, 檀碧波. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 475-480.
[7] 武慧铭, 郭仁凯, 李辉宇. 机器人辅助下经自然腔道取标本手术治疗结直肠癌安全性和有效性的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 395-400.
[8] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[9] 王晓丹, 王媛, 崔向宇, 任晓磊. 上尿路结石内镜手术后尿源性脓毒血症病原菌耐药及死亡高危因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 611-615.
[10] 刘恒, 侯宇川. 膀胱癌新型灌注药物的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 445-451.
[11] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[12] 吉茜茜, 田尧, 马林, 钱进. 红细胞分布宽度-白蛋白比值联合BISAP评分对急性胰腺炎严重程度及死亡率的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 433-438.
[13] 易成, 韦伟, 赵宇亮. 急性肾脏病的概念沿革[J]. 中华临床医师杂志(电子版), 2023, 17(08): 906-910.
[14] 邓世栋, 刘凌志, 郭大勇, 王超, 黄忠欣, 张晖辉. 沉默SNHG1基因对膀胱癌细胞增殖、凋亡、迁移和铁死亡的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 804-811.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要